Dapagliflozin In Heart Failure with Reduced Ejection Fraction (HFrEF) In Patients with Type 2 Diabetes Mellitus
Dapagliflozin▽ in Heart Failure with Reduced Ejection Fraction (HFrEF) in patients without Diabetes Mellitus
![Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes | Journal of Medicinal Chemistry Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm701272q/asset/images/large/jm-2007-01272q_0006.jpeg)
Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes | Journal of Medicinal Chemistry
![Sodium-glucose co-transporter type 2 (SGLT-2) inhibitors: dosing, dose... | Download Scientific Diagram Sodium-glucose co-transporter type 2 (SGLT-2) inhibitors: dosing, dose... | Download Scientific Diagram](https://www.researchgate.net/publication/337847025/figure/fig3/AS:837025393553410@1576573813215/Sodium-glucose-co-transporter-type-2-SGLT-2-inhibitors-dosing-dose-adjustment-and.png)
Sodium-glucose co-transporter type 2 (SGLT-2) inhibitors: dosing, dose... | Download Scientific Diagram
![Single oral doses of dapagliflozin were demonstrated to stimulate an... | Download Scientific Diagram Single oral doses of dapagliflozin were demonstrated to stimulate an... | Download Scientific Diagram](https://www.researchgate.net/publication/230742842/figure/fig1/AS:393326986579968@1470787869096/Single-oral-doses-of-dapagliflozin-were-demonstrated-to-stimulate-an-increase-in-urinary.png)